Science Strategy
In a randomized controlled trial (RCT), researchers conduct a controlled experiment to answer a research question, often regarding drug treatment or prevention strategies. The trial design typically involves an active group, which receives the intervention, and a comparator group, which receives a placebo or the standard of care. Two types of trial designs that establish the effectiveness of the drug being studied are non-inferiority trials and superiority trials. Non-inferiority trials seek to show that a new drug is not substantially worse than an active comparator, while superiority trials aim to prove that the new drug is better than a placebo or active comparator. A third type of trial design is the equivalence trial, which attempts to show one thing is equal to or as close to equal to another, such as for generic drug formulations in comparison to brand-name formulations.
RCTs involve randomization, the random assignment of study participants to the active group versus the comparator group, which helps to control for confounding variables and achieve a statistically significant measure of effect. To prevent bias in the trial, blinding is used to withhold information about treatment assignment, which can be single-blind, double-blind, or triple-blind. Challenges in RCTs include study dropout, non-compliance, and unauthorized crossover of participants between groups. The analysis of RCTs can be conducted using intent-to-treat or per protocol approaches, with the intent-to-treat being the more common and accurate method.
Lesson Outline
<ul> <li>Introduction to Randomized Controlled Trials (RCTs) <ul> <li>Rigorous scientific studies</li> <li>Interventional, not observational</li> <li>RCTs often examine drug treatment trials or prevention strategies</li> </ul> </li> <li>Defining the study sample <ul> <li>Choosing a target population for intervention</li> <li>Divide sample into two groups: active and comparator</li> <li>Comparator group may receive placebo, standard care, or an active drug</li> </ul> </li> <li>Types of trial designs <ul> <li>Non-inferiority trial: show new drug is as good as an active comparator/current standard treatment</li> <li>Superiority trial: prove new drug is better than a placebo or active comparator</li> <li>Equivalence trial: show one thing is equal to or as close to equal to another (commonly used for generic drug applications or vaccine applications)</li> </ul> </li> <li>Inclusion and exclusion criteria <ul> <li>Specify criteria for sampling participants (inclusion)</li> <li>Specify criteria that restricts study participation (exclusion)</li> <li>Consider external validity or generalizability</li> </ul> </li> <li>Study power and sample size <ul> <li>Statistical power usually pre-specified at around 80%</li> <li>Determine number of participants needed based on effect size and power</li> <li>Adding more endpoints (i.e., outcomes measured) can reduce statistical power</li> </ul> </li> <li>Randomization and blinding <ul> <li>Random assignment of participants to groups</li> <li>Single-blinded: only participants don't know group assignment</li> <li>Double-blinded: participants and investigators don't know group assignment</li> <li>Triple-blinded: participants, investigators, and treatment administrators don't know group assignment</li> </ul> </li> <li>Pitfalls: lost to follow-up, non-compliance, and unauthorized crossover <ul> <li>Lost to follow-up (study dropout) and non-compliance can create bias and reduce study power</li> <li>Unauthorized crossover can disrupt results analysis</li> </ul> </li> <li>Analysis of RCTs <ul> <li>Intent-to-treat (ITT) analysis: based on original treatment assignments</li> <li>Per protocol (efficacy) analysis: based on what participant actually took</li> </ul> </li> </ul>
Don't stop here!
Get access to 19 more MCAT Science Strategy lessons & 8 more full MCAT courses with one subscription!
FAQs
A randomized controlled trial (RCT) is a type of clinical trial where participants are randomly assigned to either the intervention group, receiving the treatment being studied, or the control group, receiving a placebo or standard treatment. RCTs are considered the gold standard for determining the effectiveness of an intervention because randomization helps eliminate potential biases and ensures that confounding variables are equally distributed among the groups. Other types of clinical trials, such as non-randomized or observational studies, may not have a control group or randomization, making it more challenging to determine causal relationships between the intervention and the observed outcomes.
The sample size in a randomized controlled trial refers to the number of participants included in the study. A larger sample size is crucial for several reasons. Firstly, it increases the statistical power of the study, which means a greater probability of detecting an effect if it truly exists. Secondly, larger sample sizes help to reduce the impact of random variation or chance, thereby increasing the reliability of the results. Additionally, larger samples provide a better representation of the population, making the results more generalizable. In order to calculate an appropriate sample size for a trial, researchers consider factors such as the expected effect size, variability within the population, and desired level of statistical significance.
Inclusion criteria are the specific characteristics that participants must have to be eligible for enrollment in a randomized controlled trial. They may include factors such as age, sex, disease stage, and medical history. Exclusion criteria, on the other hand, are conditions that disqualify potential participants from the study. These might involve factors such as allergies, pregnancy, or pre-existing medical conditions that could interfere with the study results or participant safety. Inclusion and exclusion criteria are vital because they help ensure participant safety, standardize the study population, and reduce potential biases or confounding factors that might impact the study results.
A superiority trial is a type of randomized controlled trial designed to show that a new intervention is more effective than the current standard treatment or placebo. The primary objective is to demonstrate a statistically significant and clinically meaningful improvement in outcomes (e.g., reduced symptoms or increased survival) with the new intervention. In contrast, a non-inferiority trial aims to show that a new intervention is not worse than the standard treatment by a predefined margin of clinical equivalence. This type of trial is often conducted when the new intervention offers advantages, such as improved safety, reduced cost, or easier administration, but may not necessarily provide better efficacy.
A research hypothesis is a testable statement that predicts the expected outcome of a randomized controlled trial. It typically stems from a review of current literature, clinical observations, or preliminary data suggesting a potential relationship between an intervention and a specific outcome. The hypothesis should be clearly defined, focused, and address a specific, measurable variable (e.g., treatment effectiveness, symptom improvement, or survival rate). In a randomized controlled trial, the research hypothesis is often framed as a null hypothesis, which assumes no difference between the intervention and control groups, allowing researchers to test whether their intervention produces a statistically significant and clinically relevant effect compared to the control condition.
MCAT® is a registered trademark of the Association of American Medical Colleges. The United States Medical Licensing Examination (USMLE®) is a joint program of the Federation of State Medical Boards (FSMB®) and National Board of Medical Examiners (NBME®). NAPLEX® is a registered trademark of the National Association of Boards of Pharmacy. PANCE© is a registered trademark of the National Commission on Certification of Physician Assistants. NCLEX® is a registered trademark and service mark of the National Council of State Boards of Nursing, Inc. None of the trademark holders are endorsed by nor affiliated with Sketchy or this website.
